Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.

H, Muaddi; M, D'Angelica; JT, Wiseman; M, Dillhoff; N, Latchana; R, Roke; YJ, Ko; D, Carpizo; K, Spencer; RC, Fields; G, Williams; F, Aucejo; LA, Acevedo-Moreno; KG, Billingsley; BS, Walker; SC, Mayo; PJ, Karanicolas

doi:10.1002/jso.26270

Public

Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.

Shared by NobleBlocks on Oct 23, 2020 • 12:00 AM UTC

Authors:

Muaddi H

D'Angelica M

Wiseman JT

Abstract

Introduction Hepatic artery infusion pump (HAIP) chemotherapy is a specialized therapy for patients with unresectable colorectal liver metastases (uCRLM). Its effectiveness was demonstrated from a high volume center, with uncertainty regarding the feasibility and safety at other centers. Therefore, ...

Subject

Colorectal Liver Metastasis

Hepatic Artery Infusion Pump Chemotherapy

Liver Metastases Treatment

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!